Per-Operative Levosimendan Use In High-Risk Patients Undergoing Coronary Artery Bypass Surgery
Aim:Although conventional inotropic drugs are well examined for myocardial support during weaning from cardiopulmonary bypass (CPB), there is limited experience about a new calcium sensitiser drug, levosimendan. We aimed to investigate effects of early infusion of ‘levosimendan’ started per-operativ...
Saved in:
| Main Authors: | Ulaș Kumbasar, Ali Can Hatemi, Mustafa Canikoğlu, Aybala Tongut, Mete Gürsoy, Kadir Çeviker, İlhan Özgöl, Murat Bașkurt, Cem Bostan, Kamil Karaoğlu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Publishing House
2012-04-01
|
| Series: | Ankara Üniversitesi Tıp Fakültesi Mecmuas |
| Subjects: | |
| Online Access: |
http://ankaratipfakultesimecmuasi.net/archives/archive-detail/article-preview/per-operative-levosimendan-use-n-high-risk-patient/18478
|
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effectiveness of levosimendan in newborns with low cardiac output syndrome in the multiple organ dysfunction
by: A. V. Golomidov, et al.
Published: (2025-06-01) -
PREVENTION OF HEART FAILURE IN NON-CARDIAC SURGERY WITH THE LOWER EJECTION FRACTION OF LEFT VENTRICULAR: LEVOSIMENDAN OR ANESTHETIC CARDIOPROTECTION? (randomized multi-centered trial)
by: V. V. Likhvantsev, et al.
Published: (2018-01-01) -
Bibliometric analysis of levosimendan
by: Xian-Shu Zhao, et al.
Published: (2025-02-01) -
Perioperative Predictors of Unfavorable Outcome of Vascular Surgery
by: Viktor V. Moroz, et al.
Published: (2017-06-01) -
The Use of Levosimendan for the Treatment of Heart Failure and its Potential Organoprotective Effects
by: N. B. Lebedeva, et al.
Published: (2022-05-01)